Loreline Study: Characterization of Long Responders Under Eribuline
NCT03771183
·
clinicaltrials.gov ↗
COMPLETED
Status
97
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Patients
Therapy Related Tumor
Interventions
OTHER:
Patients in long response during Halaven® treatment
Sponsor
Centre Jean Perrin